Bank of America’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146 | Buy |
168
+35
| +26% | +$30 | ﹤0.01% | 6860 |
|
|
2025
Q1 | $227 | Buy |
133
+7
| +6% | +$12 | ﹤0.01% | 6605 |
|
|
2024
Q4 | $265 | Buy |
126
+11
| +10% | +$23 | ﹤0.01% | 6603 |
|
|
2024
Q3 | $351 | Buy |
115
+19
| +20% | +$58 | ﹤0.01% | 6520 |
|
|
2024
Q2 | $267 | Sell |
96
-141
| -59% | -$392 | ﹤0.01% | 6595 |
|
|
2024
Q1 | $860 | Buy |
+237
| New | +$860 | ﹤0.01% | 6320 |
|
|
2021
Q2 | – | Sell |
-145
| Closed | -$1K | – | 7030 |
|
|
2021
Q1 | $1K | Buy |
+145
| New | +$1K | ﹤0.01% | 6598 |
|